Puma Bio Rips More Than $100 After-Hours On Trial Results For Breast Cancer

By: via Benzinga
Puma Biotechnology (NYSE: PBYI) is trading more than 180 percent higher after-hours as news hit that the company released positive ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.